-
GSK reported to have started the sale of $1.2 billion consumer health drugs
europeanpharmaceuticalreview
June 27, 2019
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
-
GSK and University of California team up on CRISPR research
pharmaceutical-technology
June 19, 2019
UK-based GlaxoSmithKline (GSK) has partnered with the University of California to carry out genomic research for drug discovery applications.
-
GSK Partners with University of California for Genomic Research
contractpharma
June 19, 2019
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome.
-
GSK to advance genomic research and improve drug discovery
biospectrumasia
June 16, 2019
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome
-
GSK, Uni of California pair up to advance genomic research
pharmatimes
June 16, 2019
Pharma giant GlaxoSmithKline (GSK) has announced plans to joins forces with the University of California, in order to advance genomic research and improve drug discovery.
-
GSK gets positive opinion for Nucala self-administration from EMA
pharmaceutical-technology
June 06, 2019
GlaxoSmithKline (GSK) has secured a positive recommendation from a European Medicines Agency (EMA) panel for its Nucala (mepolizumab) medication.
-
China approves GSK’s shingles vaccine Shingrix in adults
pharmaceutical-technology
May 29, 2019
GlaxoSmithKline (GSK) has received approval from the Chinese National Medical Products Administration (NMPA) for the use of its Shingrix vaccine to prevent shingles (herpes zoster) in adults.
-
GSK updates its sales rep incentives
pharmatimes
May 28, 2019
Specifically in Specialty Care, the capped variable pay element of a sales representative’s compensation will be evaluated on the basis of individual sales targets.
-
GSK expands bispecific antibodies deal with Zymeworks
pharmaceutical-technology
May 22, 2019
GlaxoSmithKline (GSK) has expanded its licensing and collaboration agreement with Canadian biotechnology firm Zymeworks.
-
GSK and Novartis ‘misled’ consumers, says Federal Court of Australia
europeanpharmaceuticalreview
May 21, 2019
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.